已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [American Association for Thoracic Surgery]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
newplayer完成签到,获得积分10
1秒前
3秒前
zzz发布了新的文献求助10
3秒前
ABCD完成签到 ,获得积分10
5秒前
6秒前
无花果应助123采纳,获得10
8秒前
西宁发布了新的文献求助10
8秒前
hayek完成签到,获得积分10
10秒前
Leo发布了新的文献求助10
11秒前
12秒前
12秒前
量子星尘发布了新的文献求助10
14秒前
李李李发布了新的文献求助10
16秒前
wqs发布了新的文献求助10
17秒前
jxl完成签到 ,获得积分10
17秒前
相俊杰发布了新的文献求助10
18秒前
Leo完成签到,获得积分20
18秒前
贰壹完成签到 ,获得积分10
19秒前
喜羊羊完成签到,获得积分10
22秒前
一坨完成签到,获得积分10
23秒前
Dyq发布了新的文献求助10
24秒前
28秒前
李东东完成签到 ,获得积分10
30秒前
李李李完成签到,获得积分10
35秒前
鹿七完成签到 ,获得积分10
37秒前
快乐的素完成签到 ,获得积分10
37秒前
37秒前
38秒前
硫琉流发布了新的文献求助10
41秒前
siso发布了新的文献求助10
42秒前
42秒前
唐唐完成签到 ,获得积分10
42秒前
43秒前
44秒前
浮游应助科研通管家采纳,获得10
45秒前
浮游应助科研通管家采纳,获得10
46秒前
liao应助科研通管家采纳,获得10
46秒前
JamesPei应助科研通管家采纳,获得50
46秒前
浮游应助科研通管家采纳,获得10
46秒前
46秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
List of 1,091 Public Pension Profiles by Region 1001
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 1000
Active-site design in Cu-SSZ-13 curbs toxic hydrogen cyanide emissions 500
On the application of advanced modeling tools to the SLB analysis in NuScale. Part I: TRACE/PARCS, TRACE/PANTHER and ATHLET/DYN3D 500
L-Arginine Encapsulated Mesoporous MCM-41 Nanoparticles: A Study on In Vitro Release as Well as Kinetics 500
Virus-like particles empower RNAi for effective control of a Coleopteran pest 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5463082
求助须知:如何正确求助?哪些是违规求助? 4567845
关于积分的说明 14311869
捐赠科研通 4493691
什么是DOI,文献DOI怎么找? 2461823
邀请新用户注册赠送积分活动 1450866
关于科研通互助平台的介绍 1426021